Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fyn, Blk, and Lyn kinase inhibitors: A mini-review on medicinal attributes, research progress, and future insights. | Bioorg Med Chem Lett | 2024 | 38408513 | PubTator, text mining | PubMed |
| ZNL0325, a Pyrazolopyrimidine-Based Covalent Probe, Demonstrates an Alternative Binding Mode for Kinases. | J Med Chem | 2024 | 38300264 | PubTator, text mining | PubMed |
| GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. | Nat Commun | 2024 | 38296975 | PubTator, text mining | PubMed |
| HIF‑1 and macrophage activation signalling pathways are potential biomarkers of invasive aspergillosis. | Exp Ther Med | 2024 | 38274338 | PubTator, text mining | PubMed |
| The integration of multi-omics analysis and machine learning for the identification of prognostic assessment and immunotherapy efficacy through aging-associated genes in lung cancer. | Aging (Albany NY) | 2024 | 38261733 | PubTator, text mining | PubMed |
| Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development. | Brain Sci | 2024 | 38248274 | PubTator, text mining | PubMed |
| Accelarated immune ageing is associated with COVID-19 disease severity. | Immun Ageing | 2024 | 38212801 | PubTator, text mining | PubMed |
| Location, location, location: Protein kinase nanoclustering for optimised signalling output. | Elife | 2024 | 38206309 | PubTator, text mining | PubMed |
| Association of endometriosis with Sjögren's syndrome: Genetic insights (Review). | Int J Mol Med | 2024 | 38186322 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells. | Oncogenesis | 2024 | 38177125 | PubTator, text mining | PubMed |
| FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect. | Heliyon | 2024 | 38163206 | PubTator, text mining | PubMed |
| The Relationship of Circulating Choline and Choline-Related Metabolite Levels with Health Outcomes: A Scoping Review of Genome-Wide Association Studies and Mendelian Randomization Studies. | Adv Nutr | 2024 | 38128611 | PubTator, text mining | PubMed |
| Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells. | Cancer Res | 2024 | 38095536 | PubTator, text mining | PubMed |
| A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells. | Life Sci Alliance | 2024 | 38073578 | PubTator, text mining | PubMed |
| Screening of Mutations in Maturity-onset Diabetes of the Young-related Genes and RFX6 in Children with Autoantibody-negative Type 1 Diabetes Mellitus | J Clin Res Pediatr Endocrinol | 2024 | 38054414 | PubTator, text mining | PubMed |
| A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis. | Blood Adv | 2024 | 37939259 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening. | J Biomol Struct Dyn | 2024 | 37688373 | PubTator, text mining | PubMed |
| A Case of Diabetes Mellitus Type MODY5 as a Feature of 17q12 Deletion Syndrome | J Clin Res Pediatr Endocrinol | 2024 | 36511482 | PubTator, text mining | PubMed |
| Editorial: Genetics of inflammatory and immune diseases. | Front Genet | 2023 | 38259613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=6